[1]
K. Kania, J. Kania, K. Niekurzak, M. Jędrak, M. Józefiak, and P. Sobkiewicz, “FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich’s Ataxia - Review”, J Educ Health Sport, vol. 40, no. 1, pp. 111–126, Aug. 2023.